Variation in neurocognitive and psychological symptoms between children and adults treated with elexacaftor/tezacaftor/ivacaftor (ETI)

被引：0
|
作者：
Barker, Jessica [1 ]
Krishan, Smriti [1 ]
Thomsen, Amanda [1 ]
Owens, Louisa [1 ,2 ]
Prentice, Bernadette [1 ,2 ]
机构：
[1] Sydney Childrens Hosp, Sydney, NSW, Australia
[2] Univ New South Wales, Sydney, NSW, Australia
来源：
RESPIROLOGY | 2024年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
103
引用
收藏
页码：40 / 41
页数：2
相关论文
共 50 条
  • [11] The effect of elexacaftor/tezacaftor/ivacaftor on non-pulmonary symptoms in adults with cystic fibrosis
    Allgood, Sarah
    Levy, Reena
    Bubaris, Despina
    Riekert, Kristin
    Psoter, Kevin J.
    Lechtzin, Noah
    HELIYON, 2023, 9 (09)
  • [12] Cystic fibrosis: Does it matter to avoid crushing Elexacaftor/Tezacaftor/Ivacaftor (ETI) tablets?
    Lebecque, Patrick
    Thimmesch, Matthieu
    Meurrens, Jessica
    Jeanmart, Philippe
    PEDIATRIC PULMONOLOGY, 2023, 58 (12) : 3603 - 3604
  • [13] Effects of Elexacaftor-Tezacaftor-Ivacaftor on Nasal and Sinus Symptoms in Children With Cystic Fibrosis
    Petit, Guillaume
    Coudert, Aurelie
    Hermann, Ruben
    Truy, Eric
    Bonjour, Maxime
    Reix, Philippe
    Ayari, Sonia
    PEDIATRIC PULMONOLOGY, 2025, 60 (01)
  • [14] What does it mean to be "healthy" when taking elexacaftor/tezacaftor/ ivacaftor (ETI)? A qualitative study
    Everhart, Robin S.
    Mcwilliams, Emma
    Maggs, Jill
    Sawicki, Gregory S.
    Sconiers, Takeera
    Smith, Kyle
    Yablon, Dana
    Butcher, Jennifer
    Prickett, Michelle
    Bacon, Callie
    Goodman, Andrea
    Gifford, Alex H.
    Mayer-Hamblett, Nicole
    Nichols, David P.
    Riekert, Kristin A.
    JOURNAL OF CYSTIC FIBROSIS, 2025, 24 (01) : 187 - 192
  • [15] The Effects of Elexacaftor, Tezacaftor, and Ivacaftor (ETI) on Blood Glucose in Patients With Cystic Fibrosis: A Systematic Review
    Salazar-Barragan, Marcelo
    Taub, Daniel R.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [16] Reversal of cylindrical bronchial dilatations in a subset of adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor
    Cazier, Paul
    Chassagnon, Guillaume
    Dhote, Theo
    Da Silva, Jennifer
    Kanaan, Reem
    Honore, Isabelle
    Carlier, Nicolas
    Revel, Marie-Pierre
    Canniff, Emma
    Martin, Clemence
    Burgel, Pierre-Regis
    EUROPEAN RESPIRATORY JOURNAL, 2024, 63 (03)
  • [17] Elexacaftor/Ivacaftor/tezacaftor/IvacaftorDepressive symptoms and suicidal thoughts: case report
    Reactions Weekly, 2025, 2053 (1) : 142 - 142
  • [18] Characterization of sleep in emerging adults with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor
    Meltzer, Lisa J.
    Gross, Jane E.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (01) : 132 - 136
  • [19] Correlation between trough concentration and AUC for elexacaftor, tezacaftor and ivacaftor
    Vonk, Steffie E. M.
    Altenburg, Josje
    Mathot, Ron A. A.
    Kemper, E. Marleen
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (05) : 1007 - 1009
  • [20] Disproportionate rates of liver impairment in Australian cystic fibrosis patients initiated on elexacaftor/tezacaftor/ivacaftor (ETI)
    Johnson, Ellie
    Evans, Ieuan
    Reid, David
    RESPIROLOGY, 2024, 29 : 27 - 27
12345